In addition, combined administration of the dual mTOR/DNA-PK Inhibitor CC-115 and radiotherapy has been shown to inhibit tumor growth and significantly reduce the migration rate in HNSCC cell lines [236]. The gene discussed is PRKDC; the disease is neoplasm.